Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Category : Search result: central obesity
Assam Police Fitness: 2.06% Obese in BMI Drive
Assam Police reports significant fitness improvement with only 2.06% of 73,317 personnel classified as obese in annual BMI tests. Discover how the force is getting leaner and mission-ready.
Mumbai teen beats Type 2 diabetes with lifestyle overhaul
A 16-year-old Mumbai student reversed his Type 2 diabetes risk factors. Discover how an endocrinologist's plan involving diet, exercise, and family support led to a 7 kg weight loss and improved HbA1c levels in six months.
Arjun Kapoor on Therapy, Mental Health & Obesity
Arjun Kapoor speaks candidly about his mental health journey, starting therapy during lockdown, and overcoming obesity. Read his powerful message on strength.
Man dies after weight-loss surgery to impress in-laws
A 36-year-old Chinese man died days after gastric bypass surgery he hoped would help him impress his girlfriend's parents. The tragedy sparks debate about weight-loss surgery risks.
Child hypertension doubled since 2000: Lancet study
Lancet study shows child hypertension doubled 2000-2020. 114 million affected globally. Obesity, poor diet, sedentary lifestyles identified as key triggers. Learn prevention strategies.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Youth Health Crisis: Obesity & Heart Attacks Rising in India
Medical experts warn of alarming surge in obesity and heart attacks among young Indians. Discover how adopting Blue Zone lifestyle principles could reverse this dangerous trend.
Trump courts Central Asia to bypass China rare earth dominance
In a bold geopolitical chess move, former President Donald Trump hosts Central Asian leaders to secure alternative rare earth metals supply chains, challenging China's global monopoly on these critical minerals.
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
America's Obesity Crisis: Most & Least Overweight States Revealed
New data exposes America's weight divide: Discover which states top the obesity charts and which maintain healthier lifestyles in this comprehensive health analysis.
Trump's $149 Weight-Loss Drug Deal with Ozempic Maker
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
70kg Weight Loss: Simple Hack That Changed Everything
Discover how one woman transformed her life by losing 70kg without relying on willpower alone. Her surprising revelation about what really causes weight gain will change everything you thought you knew about dieting.
FDA Approves Oral Weight Loss Drug Rybelsus
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
New Weight Loss Drugs: India's Medical Revolution
Explore how revolutionary weight-loss medications like Ozempic are transforming lives while raising crucial questions about accessibility, side effects, and long-term sustainability in the Indian context.
Sudden Weight Changes Can Damage Your Kidneys
Discover the hidden connection between rapid weight fluctuations and kidney damage. Learn about risk factors, prevention tips, and when to seek medical help.
India wraps up operations at Tajikistan's Ayni Airbase
India concludes military operations at Tajikistan's Ayni Airbase as key defense pact expires, marking a significant shift in Central Asian strategy. Explore the implications for regional security and India's diplomatic future in the heart of Asia.
Breathless Walking? 8 Health Reasons Why
Discover the surprising medical conditions that could be causing your breathlessness during simple walks. Learn when to seek medical attention for this common symptom.
Weight Loss Shots: Bengaluru Doctors Issue Warning
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.
Eli Lilly's Diabetes & Weight Loss Pill Replaces Injections
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Pay Commission Triggers Union Outrage Over Benefit Cuts
Trade unions erupt in anger as 8th Central Pay Commission recommendations threaten to slash employee benefits. DA merger, LTC restrictions, and medical coverage changes trigger nationwide protests.
Dark Neck Patches: India's Child Obesity Warning
Acanthosis Nigricans, the dark skin patch on children's necks, is emerging as a visible warning sign of India's growing childhood obesity crisis and early diabetes risk.
How GLP-1 Drugs Are Quietly Reshaping America's Waistline
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Ex-Novo CEO: Drugs Alone Can't Solve Obesity
Former Novo Nordisk CEO Lars Fruergaard Jørgensen reveals why revolutionary weight-loss drugs need comprehensive healthcare strategies to tackle obesity effectively. Discover the missing pieces in the fight against this global epidemic.
India's Obesity Crisis: Economic Impact Revealed
India faces a dual health crisis as obesity rates surge alongside undernutrition, creating a massive economic burden that threatens national productivity and healthcare systems.
Weight Gain's Hidden Damage to Skin & Hair
Discover how excess weight secretly damages your skin elasticity, causes hair thinning, and triggers premature aging. Expert insights on the surprising connection between weight and beauty.
Page 3 of 4